Year Book of Dermatology - 2018 Psoriasis
Clasificación: | Libro Electrónico |
---|---|
Autor principal: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Delhi :
Jaypee Brothers Medical Publishers,
2019.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Cover
- Book Title
- Copyright Page
- Dedicated
- Contributors
- Foreword
- Preface
- Contents
- Article-1: Apremilast in Psoriasis-A Prospective Real-world Study
- Article-2: Comparative Effectiveness of Abatacept, Apremilast, Secukinumab and Ustekinumab Treatment of Psoriatic Arthritis: A Systematic Review and Network Meta-analysis
- Article-3: Management of Common Side Effects of Apremilast
- Article-4: Apremilast for the Treatment of Moderate-to-Severe Palmoplantar Psoriasis: Results from a Double-Blind, Placebo-Controlled, Randomized Study
- Article-5: Long-term Safety and Tolerability of Apremilast in Patients with Psoriasis: Pooled Safety Analysis for ≥156 Weeks from 2 Phase 3, Randomized Controlled Trials (ESTEEM 1 and 2)
- Article-6: Secukinumab and Apremilast Combination Therapy for Recalcitrant Psoriasis
- Article-7: Apremilast: A Review in Psoriasis and Psoriatic Arthritis
- Article-8: Serum Squamous Cell Carcinoma Antigen in Psoriasis: A Potential Quantitative Biomarker for Disease Severity
- Article-9: Long-term Real-life Safety Profile and Effectiveness of Fumaric Acid Esters in Psoriasis Patients: A Single-Centre, Retrospective, Observational Study
- Article-10: Association between Circulating 25-hydroxyvitamin D Levels and Psoriasis, and Correlation with Disease Severity: A Metaanalysis
- Article-11: Maintenance of Skin Clearance with Ixekizumab Treatment of Psoriasis: Three-Year Results from the UNCOVER-3 Study
- Article-12: Psoriasis and the Risk of Diabetes: A Prospective Populationbased Cohort Study
- Article-13: Psoriatic Patients with Chronic Viral Hepatitis do not have an Increased Risk of Liver Cirrhosis Despite Long-term Methotrexate Use: Real-world Data from a Nationwide Cohort Study in Taiwan
- Article-14: Reporting of Outcomes in Randomized Controlled Trials on Nail Psoriasis: A Systematic Review
- Article-15: Risk of Cancer in Patients with Psoriasis on Biological Therapies: A Systematic Review
- Article-16: Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis
- Article-17: Secukinumab Treatment of Moderate to Severe Plaque Psoriasis in Routine Clinical Care: Real-life Data of Prior and Concomitant Use of Psoriasis Treatments from the PROSPECT Study
- Article-18: Serum Levels of Psoriasin (S100A7) and Koebnerisin (S100A15) as Potential Markers of Atherosclerosis in Patients with Psoriasis
- Article-19: Simulating the Life Course of Psoriasis Patients: The Interplay between Therapy Intervention and Marital Status
- Article-20: Smoking Paradox in the Development of Psoriatic Arthritis among Patients with Psoriasis: A Population-based Study